Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011426 · ClinicalTrials.gov registry record · Phase 2
Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients
A Phase 2 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 285
- Enrollment target
NCT01011426 is a Phase 2 study that has completed, run by The Cooper Health System. The registered enrollment target is 285 participants.
The verdict
NCT01011426, a Phase 2 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 285 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.
Interventions
- DRUG placebo
- DRUG Bisacodyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01011426
The ClinicalTrials.gov registry entry for NCT01011426 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01011426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01011426 about?
NCT01011426 is a clinical study titled "Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients". The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.
What is the current status of trial NCT01011426?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 285 participants. The study started on 2009-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01011426?
The interventions under investigation include: placebo (DRUG), Bisacodyl (DRUG).
Who is sponsoring clinical trial NCT01011426?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.